"No Compromise On Safety": Centre On COVID-19 Vaccine Deadline


The World Health Organization (WHO) says there are 19 vaccine trials in clinical evaluation and hundreds being developed and tested around the world to stop the COVID-19 pandemic, which has killed hundreds of thousands of people and ravaged the global economy. Drug Controller General of India gave nod to the Phase 1 and Phase 2 human clinical trials.

"The Chinese national regulatory authority has been improving its oversight", said Jerome Kim, head of the International Vaccine Institute, a non-profit agency established as an initiative of the UN Development Programme. "The aim of the letter was to ask sites to fast track it".

The PLA has its own approval process for "military specifically-needed drugs", the report said, and approved the military use of the candidate developed by its research unit and CanSino last month.

"We need the vaccine today".

According to the Union Ministry of Science and Technology, more than 140 candidate COVID-19 vaccines are now under various stages of development across the world out of which 11 have reached the human trial phases.

COVID-19 herd immunity might not be possible
During the study , researchers at the Institute of Health Carlos III in Madrid, the Spanish Ministry of Health and Harvard's T.H. The third-phase results will be released next Monday and are expected to align closely with the current figures.

The COVPN is a functional unit of "Operation Warp Speed", a partnership led by the U.S. Department of Health and Human Services (HHS) to invest in and coordinate the development, manufacturing and distribution of COVID-19 diagnostics, therapeutics and vaccines.

Several countries are pushing to have vaccines ready as soon as possible, including the United States and the United Kingdom, both of which have vaccines in advanced levels of testing. The crux of the guideline was that India should consider the research collaborations that are taking place with Indian enterprises and foreign research organisations and prioritise the approval process for various phases of clinical trials on the basis of data generated elsewhere too.

"Whenever the results of these trials come, we will put the results in front of you", he said. NIMS director K. Manohar said that screening of participants is on. You have been chosen as a clinical trial site of the BBV152 COVID vaccine.

The subject enrolment for Phase-I clinical trial of India's first indigenous vaccine for COVID-19 began at Nizam's Institute of Medical Science (NIMS). "Therefore, you are advised to treat this project on highest priority and meet the given timelines without any lapse", the letter had said.

"Kindly note non-compliance will be viewed very seriously".